SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001615774-17-000400
Filing Date
2017-02-07
Accepted
2017-02-07 16:31:25
Documents
43
Period of Report
2016-12-31

Document Format Files

Seq Description Document Type Size
1 10-Q s105222_10q.htm 10-Q 331926
2 EXHIBIT 31.1 s105222_ex31-1.htm EX-31.1 7022
3 EXHIBIT 31.2 s105222_ex31-2.htm EX-31.2 6994
4 EXHIBIT 32.1 s105222_ex32-1.htm EX-32.1 4625
  Complete submission text file 0001615774-17-000400.txt   2177411

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE FILE avxl-20161231.xml EX-101.INS 437060
6 XBRL SCHEMA FILE avxl-20161231.xsd EX-101.SCH 27160
7 XBRL CALCULATION FILE avxl-20161231_cal.xml EX-101.CAL 29782
8 XBRL DEFINITION FILE avxl-20161231_def.xml EX-101.DEF 83919
9 XBRL LABEL FILE avxl-20161231_lab.xml EX-101.LAB 205205
10 XBRL PRESENTATION FILE avxl-20161231_pre.xml EX-101.PRE 138848
Mailing Address 51 W 52ND STREET, 7TH FLOOR NEW YORK NY 10019-6163
Business Address 51 W 52ND STREET, 7TH FLOOR NEW YORK NY 10019-6163 800-689-3939
ANAVEX LIFE SCIENCES CORP. (Filer) CIK: 0001314052 (see all company filings)

IRS No.: 208365999 | State of Incorp.: NV | Fiscal Year End: 0930
Type: 10-Q | Act: 34 | File No.: 001-37606 | Film No.: 17579454
SIC: 8731 Services-Commercial Physical & Biological Research